Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 17 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| EXICURE, INC. | 324,473 | reported | 06 Jul 2020 | tx 15+784,430−22,240 |
| Oncothyreon Inc. | 100,000 | reported | 16 Dec 2014 | tx 6+4,740,216 |
| Nivalis Therapeutics, Inc. | 70,000 | reported | 15 Jul 2022 | tx 21+4,492,627−1,429,164 |
| IOVANCE BIOTHERAPEUTICS, INC. | 35,000 | reported | 01 Jun 2017 | tx 5+195,000 |
| Serina Therapeutics, Inc. | 10,000 | reported | 07 Nov 2025 | tx 3+146,525 |
| Targanta Therapeutics Corp. | 10,000 | reported | 02 Jun 2008 | tx 7+2,806,682−1,757,346 |
| Elicio Therapeutics, Inc. | 7,900 | reported | 19 May 2025 | tx 40+2,797,632−1,076,696 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 07 Nov 2025 | GRANT_AWARD | Serina Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 19 May 2025 | GRANT_AWARD | Elicio Therapeutics, Inc. | 7,900 | 0.00 USD | deriv |
| 08 Apr 2025 | GRANT_AWARD | Serina Therapeutics, Inc. | 96,525 | 5.18 USD | deriv |
| 12 Feb 2025 | GRANT_AWARD | Serina Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 26 Nov 2024 | EXERCISE | Elicio Therapeutics, Inc. | 50,000 | 0.01 USD | |
| 26 Nov 2024 | EXERCISE | Elicio Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 21 Nov 2024 | GRANT_AWARD | Elicio Therapeutics, Inc. | 4,100 | 0.00 USD | deriv |
| 28 Jun 2024 | PURCHASE | Elicio Therapeutics, Inc. | 50,000 | 4.99 USD | deriv |
| 28 Jun 2024 | PURCHASE | Elicio Therapeutics, Inc. | 50,000 | 4.99 USD | deriv |
| 28 Jun 2024 | PURCHASE | Elicio Therapeutics, Inc. | 50,000 | 0.00 USD | derivfirst after silence |
| 28 Jun 2024 | PURCHASE | Elicio Therapeutics, Inc. | 50,000 | 4.99 USD | deriv |
| 28 Jun 2024 | PURCHASE | Elicio Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 28 Jun 2024 | PURCHASE | Elicio Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 28 Jun 2024 | PURCHASE | Elicio Therapeutics, Inc. | 50,000 | 4.99 USD | deriv |
| 28 Jun 2024 | PURCHASE | Elicio Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 28 Dec 2023 | GRANT_AWARD | Elicio Therapeutics, Inc. | 4,100 | 0.00 USD | deriv |
| 15 Jul 2022 | EXERCISE | Nivalis Therapeutics, Inc. | 20,063 | 0.45 USD | |
| 15 Jul 2022 | EXERCISE | Nivalis Therapeutics, Inc. | 20,063 | 0.45 USD | deriv |
| 25 May 2022 | PURCHASE | Elicio Therapeutics, Inc. | 11,313 | 1.25 USD | |
| 24 May 2022 | PURCHASE | Elicio Therapeutics, Inc. | 32,200 | 1.24 USD | |
| 20 May 2022 | PURCHASE | Elicio Therapeutics, Inc. | 50,000 | 1.23 USD | |
| 03 Mar 2022 | GRANT_AWARD | Elicio Therapeutics, Inc. | 160,000 | 0.00 USD | deriv |
| 03 Mar 2022 | GRANT_AWARD | Elicio Therapeutics, Inc. | 600,000 | 0.00 USD | deriv |
| 03 Jan 2022 | GRANT_AWARD | Nivalis Therapeutics, Inc. | 10,000 | 0.00 USD | deriv |
| 27 Dec 2021 | PURCHASE | Elicio Therapeutics, Inc. | 66,907 | 2.55 USD |
4 purchases reported after at least 12 months of silence — most recent on 28 Jun 2024.